Location: | Newcastle upon Tyne |
---|---|
Salary: | £34,866 to £36,924 with progression to £45,163 per annum. |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 12th December 2024 |
---|---|
Closes: | 5th January 2025 |
Job Ref: | 27830 |
We are a world class research-intensive university. We deliver teaching and learning of the highest quality. We play a leading role in economic, social and cultural development of the North East of England. Attracting and retaining high-calibre people is fundamental to our continued success.
The Role
The Senior Scientific Officer/Trials Analyst will be responsible for the coordination of research projects in the Newcastle Cancer Centre Pharmacology Group of Professor Gareth Veal, a leading international centre in the development and validation of clinical pharmacology assays in the field of oncology. The role involves the coordination and management of multiple projects relating to the analysis and quantification of anticancer drug levels in clinical samples obtained as part of national clinical pharmacology trials. Additional preclinical assay development work may also be involved. You will take responsibility for leading individual projects, involving the validation of novel assays and analysis of clinical samples, and the implementation of new programs of research utilising your high level of expertise in assay development. This expansive role will incorporate collaboration with a wide variety of people including university research staff/students, analytical technicians from external companies, clinicians/research nursing staff in national treatment centres and representatives from charities and funding bodies.
This new post is funded by Cancer Research UK and is available on a full-time basis for a 5-year period. The post will provide opportunities for you to further develop your skillset in an active research group.
You will have experience in clinical pharmacology assay development, primarily focusing on the use of ELISA approaches for the quantification of antibody therapies. Experience of working with automated ELISA platforms is desirable. You will be required to plan and carry out the development and validation of novel assays to facilitate the analysis of clinical trial samples. All work will be carried out according to GCLP regulations.
The Newcastle Cancer Centre Pharmacology Group is a dedicated team of experienced researchers. We have a proven track record in running clinical pharmacology studies in an oncology setting, working in close collaboration with Cancer Research UK, academia and pharma and biotech companies (https://www.ncl.ac.uk/cancer/our-research/late-phase-trials/pharmacology/).
Further information can be obtained by contacting Professor Gareth Veal (gareth.veal@ncl.ac.uk).
Find out more about the Faculty of Medical Sciences here: https://www.ncl.ac.uk/medical-sciences/.
Find out more about our Research Institutes here: https://www.ncl.ac.uk/medical-sciences/research/institutes/.
As part of our commitment to career development for research colleagues, the University has developed 3 levels of research role profiles. These profiles set out firstly the generic competences and responsibilities expected of role holders at each level and secondly the general qualifications and experiences needed for entry at a particular level.
The role is fixed-term until 16 June 2028.
Please note that if you are successful to this role, you will require a Research Passport and medical clearance before you can commence in the role.
Qualifications
Desirable:
Type / Role:
Subject Area(s):
Location(s):